2011
DOI: 10.1016/j.jpedsurg.2011.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Abdominal inflammatory myofibroblastic tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
16
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(18 citation statements)
references
References 40 publications
1
16
1
Order By: Relevance
“…The present study included 33.3% each of intrapulmonary and intra-abdominal locations followed by other locations. There was slight male predominance in the literature [10,11]; however, there was an equal incidence in each gender in the present study.…”
Section: Discussioncontrasting
confidence: 72%
See 1 more Smart Citation
“…The present study included 33.3% each of intrapulmonary and intra-abdominal locations followed by other locations. There was slight male predominance in the literature [10,11]; however, there was an equal incidence in each gender in the present study.…”
Section: Discussioncontrasting
confidence: 72%
“…Fragoso et al . [11] in 2011 stated that, although surgical resection is the preferred treatment for inflammatory myofibroblastic tumors, cases which are not amenable to surgical excision may be treated conservatively.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, IMT can present with variable clinical symptoms according to the site of tumor origin. IMT is primarily a soft tissue tumor in young adults, most frequently occurring in the first two decades of life, but IMT may occur over a wider age range (3 weeks to 74 years) [2,5,6,7]. In Korea, there have been few reported infantile cases with the youngest patient being a 3 month-old infant with IMT at the transverse colon mesentery [8].…”
Section: Discussionmentioning
confidence: 99%
“…The etiology of IMT has not been fully described and is currently regarded as a specific neoplastic lesion with inflammatory sclerosing and fibrosing processes that may be recognized by cytogenetic aberrations such as ALK gene rearrangement, p53 mutation, and MDM2 expression [3,7]. Those associations may act as prognostic indicators that could suggest the need for aggressive clinical behavior, particularly when the IMT exhibits a combination of cellular atypia, ganglion-like cells, aneuploidy, and p53 overexpression [3,9].…”
Section: Discussionmentioning
confidence: 99%
“…Myofibroblastic tumors usually have capsules, with a clear boundary, and are rarely necrotic and mitotic. The only similarity is that vimentin, desmin, and SMA are also often positively expressed in myofibroblastic tumors 12,14. For the mesenchymal breast tumor, phyllodes tumor and metaplastic carcinoma should be considered first 14…”
Section: Discussionmentioning
confidence: 99%